Cargando…
Corrigendum to “Peritumoral EpCAM Is an Independent Prognostic Marker after Curative Resection of HBV-Related Hepatocellular Carcinoma”
Autores principales: | Dai, Xiao-Meng, Huang, Tao, Yang, Sheng-Li, Zheng, Xiu-Mei, Chen, George G., Zhang, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632465/ https://www.ncbi.nlm.nih.gov/pubmed/29085181 http://dx.doi.org/10.1155/2017/3765279 |
Ejemplares similares
-
Peritumoral EpCAM Is an Independent Prognostic Marker after Curative Resection of HBV-Related Hepatocellular Carcinoma
por: Dai, Xiao-Meng, et al.
Publicado: (2017) -
EpCAM (CD326) finding its role in cancer
por: Baeuerle, P A, et al.
Publicado: (2007) -
Corrigendum to “Molecular Characterization of a Fully Human Chimeric T-Cell Antigen Receptor for Tumor-Associated Antigen EpCAM”
por: Shirasu, Naoto, et al.
Publicado: (2015) -
Corrigendum to “Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models”
por: Zhang, Qing, et al.
Publicado: (2019) -
The detection of EpCAM(+) and EpCAM(–) circulating tumor cells
por: Wit, Sanne de, et al.
Publicado: (2015)